BERD Seminar: Considerations for multiple testing correction and some common approaches
Richard Barfield, PhD

Precision Medicine Program Forum Series: "VA Precision Oncology"
Michael J. Kelley, MD

Towards neoantigen targeting personalized cancer immunotherapies which actually work
Alex Rubinsteyn, PhD


Biochemical activity is the default DNA state in eukaryotes
Carl de Boer, PhD
